Performist
Showing 1 - 3 of 3
Alzheimer's Disease, Cognitive Dysfunction Trial in Palo Alto (Formoterol A, Formoterol B ())
Withdrawn
- Alzheimer's Disease
- Cognitive Dysfunction
- Formoterol A
- Formoterol B (placebo)
-
Palo Alto, CaliforniaVA Palo Alto Health Care System
Sep 14, 2020
COPD (COPD) Trial in United States (Revefenacin, Placebo, Formoterol)
Completed
- Chronic Obstructive Pulmonary Disease (COPD)
- Revefenacin
- +2 more
-
Miami, Florida
- +11 more
Feb 22, 2022
COPD - COPD Trial in United States (Formoterol fumarate (6 µg), Formoterol furmarate (20 µg), Placebo for formoterol fumarate)
Completed
- Chronic Obstructive Pulmonary Disease - COPD
- Formoterol fumarate (6 μg)
- +4 more
-
Glendale, Arizona
- +19 more
Jan 11, 2018